The invention concerns a method for treating depression or senile dementia using a compound which acts selectively as an agohist of gamma aminobutyric acid (GABA) at GABA autoreceptors with the proviso that the compound is not fengabine and progabide.
本发明涉及一种用化合物治疗抑郁症或老年痴呆症的方法,该化合物在
GABA自身受体上具有选择性地作为
GABA受体激动剂作用,但前提是该化合物不是fengabine和progabide。